World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20140903004
Date of registration: 03/09/2014
Prospective Registration: Yes
Primary sponsor: Faculty of Medicine
Public title: Facial acupuncture combined with body acupuncture for melasma treatment
Scientific title: Facial acupuncture combined with body acupuncture for melasma treatment
Date of first enrolment: 01/10/2014
Target sample size: 50
Recruitment status: Completed
URL:  https://www.thaiclinicaltrials.org/show/TCTR20140903004
Study type:  Interventional
Study design:  Randomized  
Phase:  Phase 2/Phase 3
Countries of recruitment
Thailand
Contacts
Name: Lakkana    Rerksuppaphol
Address:  Department of Preventive Medicine, Srinakharinwirot University 26120 NakornNayok Thailand
Telephone: 0818483183
Email: lakkana_r@hotmail.com
Affiliation:  Srinakharinwirot University
Name: Lakkana    Rerksuppaphol
Address:  Department of Preventive Medicine, Srinakharinwirot University 26120 NakornNayok Thailand
Telephone: 0818483183
Email: lakkana_r@hotmail.com
Affiliation:  Srinakharinwirot University
Key inclusion & exclusion criteria
Inclusion criteria: malasma with not currently treat withany methods
Exclusion criteria: bleeding trendency or commence on anticoagulants or thrombolytic drugs, pregnency, uncontrolled hypertension, mental disorders

Age minimum: 18 Years
Age maximum: 60 Years
Gender: Female
Health Condition(s) or Problem(s) studied
acupuncture, melasma
Melasma
acupuncture, melasma
Intervention(s)
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Facial acupuncture with body acupuncture,Facial acupuncture
Particopants in group 1 (facial and boby acupuncture) will needled at the body region including Qihai (CV6), Xuchai (SP10), Zusanli (ST36), Hegu (LI4), Taichong (LR3), Sanyinjiao (SP6) and facial acupoints around melasma. The needles will removed after 30 minutes in each session. Participants will treated for 2 sessions per week for 8 consecutive weeks.,Participants in group 2 (facialacupuncture) will needled only at facial acupoints around melasma. The needles will removed after 30 minutes in each session. Participants will treated for 2 sessions per week for 8 consecutive weeks.
Primary Outcome(s)
Melasma 8 weeks after treatment area and colour scale
Secondary Outcome(s)
side effects during 8 weeks treatment period numbers of side effect reported
Secondary ID(s)
Source(s) of Monetary Support
Faculty of Medicine Srinakharinwirot University
Secondary Sponsor(s)
Srinakharinwirot University
Ethics review
Status: Submitted, approved
Approval date:
Contact:
Srinakharinwirot University
026495000 Ext. 11014
Results
Results available:
Date Posted:
Date Completed: 30/09/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history